MACAU DAILY TIMES 澳門每日時報

Top Menu

  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia

Main Menu

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
logo
FOUNDER & PUBLISHER Kowie Geldenhuys
EDITOR-IN-CHIEF Paulo Coutinho
Macau,

MACAU DAILY TIMES 澳門每日時報

  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • China-Russia-US Heads of State Declaration toward Peace

  • APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

  • Lawmakers call for stronger building management and measures to stabilize property market

  • Bill sets five grounds for dissolution of civil associations

  • Pansy Ho urges unified Greater Bay Area tourism strategy

  • Lawmakers get more speaking time under revised policy debate format

World
Home›World›AstraZeneca agrees to make Covid-19 vaccine for Europe

AstraZeneca agrees to make Covid-19 vaccine for Europe

By -
Monday, June 15, 2020
84
0

Drugmaker AstraZeneca struck a deal yesterday [Macau time] to supply up to 400 million doses of an experimental COVID-19 vaccine to European Union countries, the latest in a series of agreements as scientists, governments and pharmaceutical companies race to combat the virus.
AstraZeneca plans to begin delivering the vaccine to European countries by the end of this year under the agreement with the Inclusive Vaccine Alliance, formed this month by France, Germany, Italy and the Netherlands. All other EU member states will have the chance to take part under the same terms as the original alliance members.
The cost of making the vaccine, which was developed by Oxford University, is expected to be offset by funding from the governments.
“This agreement will ensure that hundreds of millions of Europeans have access to Oxford University’s vaccine following approval,” AstraZeneca CEO Pascal Soriot said in a prepared statement. “With our European supply chain due to begin production soon, we hope to make the vaccine available widely and rapidly.”
The deal is the latest in a series of agreements to produce the vaccine — even though it is not certain it will work to prevent coronavirus infections. Because of the desperate need for a vaccine amid the pandemic that has killed more than 426,000 people worldwide, AstraZeneca is scaling up manufacturing with human trials still under way.
The Anglo-Swedish company recently completed similar agreements with Britain, the United States, the Coalition for Epidemic Preparedness Innovations, a public-private-charitable partnership based in Norway, and Gavi, the Vaccine Alliance, another public-private partnership headquartered in Geneva, for 700 million doses. It plans to produce an additional 1 billion doses under a deal with the Serum Institute of India.
Soriot told reporters that conversations were also under way with the governments of many other nations, including Japan, Russia and Brazil.
“We are also looking at China,’’ he said, “China, as you know, are developing their own vaccines. […] It’s important to make several bets on different vaccines in every country.’’
The vaccine was developed by Oxford University’s Jenner Institute, working with the Oxford Vaccine Group.
Testing of the experimental COVID-19 vaccine began in April with a study involving over 1,000 healthy volunteers in Britain aged 18 to 55. Another round of testing with 10,000 volunteers began last month.
Other companies, including Moderna and Sanofi, are racing to develop and produce a vaccine to protect against the new coronavirus, a step experts say will be crucial to allowing countries to ease public health lockdowns and restrictions on public life. DANICA KIRKA, LONDON, AP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

Like this:

Like Loading…

Related

Previous Article

Australia ‘disheartened’ by death sentence in China

Next Article

This Day in History | 1974 Man ...

Related articles More from author

  • World

    World Briefs

    Wednesday, April 1, 2020
    By -
  • World

    AI-powered misinformation is the world’s biggest short-term threat

    Friday, January 12, 2024
    By -
  • World

    German exit polls: Nationalists strong, Merkel party weak

    Monday, September 5, 2016
    By -
  • World

    US-Israel | Amid warnings, Trump forges ahead on Jerusalem-as-capital

    Thursday, December 7, 2017
    By -
  • World

    Three ancient shipwrecks discovered off Aegean island of Kasos

    Tuesday, November 5, 2019
    By -
  • World

    Climate | 2017 set to be among top 3 hottest years, UN weather agency says

    Tuesday, November 7, 2017
    By -

Leave a reply Cancel reply

You must be logged in to post a comment.

  • Macau

    Parq Vancouver misses debt payment as casino seeks to refinance

  • China

    Threatened by Trump tariffs, Japan walks a delicate tightrope between US and China

  • Macau

    Pessimistic about EU future

DAILY EDITION

Friday, November 20, 2026 – edition no. 5079
Friday, November 20, 2026 – edition no. 5079

Greater Bay

MDT MACAU GRAND PRIX SPECIAL

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    

Timeline

  • Friday, November 20, 2026

    China-Russia-US Heads of State Declaration toward Peace

  • Friday, November 20, 2026

    APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

  • Friday, November 20, 2026

    Lawmakers call for stronger building management and measures to stabilize property market

  • Friday, November 20, 2026

    Bill sets five grounds for dissolution of civil associations

  • Friday, November 20, 2026

    Pansy Ho urges unified Greater Bay Area tourism strategy

  • Friday, November 20, 2026

    Lawmakers get more speaking time under revised policy debate format

  • Friday, November 20, 2026

    Over 85% of resident owners say Iao Hon redevelopment cannot wait

  • Friday, November 20, 2026

    Porsche leads surprise charge in opening GT World Cup sessions

  • Friday, November 20, 2026

    Rivera leads provisional FR World Cup qualifying after crash-hit session

  • Friday, November 20, 2026

    Red flags interrupt F4 practice as Killion tops timesheets

Extra Times

Drive InExtra Times

‘Madden’ biopic can’t find a playbook to stick with

Which play to run is a question that can bedevil any football coach, and it’s also what dooms David O. Russell’s fumbled biopic “Madden.” “Madden” may sport an all-star cast ...
  • Juksunchae: A Study in Precision and Contemporary Korean Cuisine

    By Irene Sam, MDT
    Friday, November 20, 2026
  • Reframing the “Hundreds of Flavors”: Chiang and Ho at Zi Yat Heen

    By -
    Friday, November 20, 2026
  • Three chefs. One horizon. Six Michelin stars

    By Irene Sam, MDT
    Friday, November 13, 2026
  • James Gray delivers a milestone crime drama in ‘Paper Tiger’

    By MDT/AP
    Friday, November 13, 2026
  • Recent

  • Popular

  • China-Russia-US Heads of State Declaration toward Peace

    By XINHUA
    Friday, November 20, 2026
  • APEC leaders back Shenzhen trade agenda as Xi meets Trump and Putin

    By Times Reporter
    Friday, November 20, 2026
  • Lawmakers call for stronger building management and measures to stabilize property market

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Bill sets five grounds for dissolution of civil associations

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Pansy Ho urges unified Greater Bay Area tourism strategy

    By Nadia Shaw, MDT
    Friday, November 20, 2026
  • Lawmakers get more speaking time under revised policy debate format

    By -
    Friday, November 20, 2026
  • Over 85% of resident owners say Iao Hon redevelopment cannot wait

    By Yuki Lei, MDT
    Friday, November 20, 2026
  • Canidrome may have its days numbered, decision in ‘one or two months’

    By Paulo Coutinho, MDT
    Thursday, May 26, 2016
  • Animal Welfare | Macau: Anima slams Canidrome management for avoiding debate

    By -
    Wednesday, May 4, 2016
  • Editorial | Canidoomed

    By Paulo Coutinho, MDT
    Wednesday, June 1, 2016
  • Animal Welfare | Canidrome presented with ultimatum: close or move

    By Daniel Beitler, MDT
    Friday, July 22, 2016
  • Australia regulator cracks down on alleged exportation of dogs to Macau

    By Paulo Coutinho, MDT
    Friday, June 10, 2016
  • Animal rights | Canidrome: Anima in fresh airline negotiations as Canidrome closure looks more likely

    By Daniel Beitler, MDT
    Friday, May 27, 2016
  • USE OF ENGLISH IN MACAU | A ‘de facto’ official language

    By Catarina Pinto
    Monday, July 6, 2015
  • Contact our Administrator
  • Contact our Editor-in-Chief
  • Contacts
  • Our Team
  • Privacy Policy
  • Terms and Conditions
  • Editorial Statute
  • Code of Ethics
COPYRIGHT © MACAU DAILY TIMES 2008-2026. ALL RIGHTS RESERVED
MACAU DAILY TIMES
  • Home
  • Macau
    • Photo Shop
    • Advertorial
  • Interview
  • Greater Bay
  • Business
    • Corporate Bits
  • China
  • Asia
  • World
  • Sports
  • Opinion
    • Editorial
    • Our Desk
    • Business Views
    • China Daily
    • Multipolar World
    • The Conversation
    • World Views
  • Our Team
  • Editorial Statute
    • Code of Ethics
    • Privacy Policy
    • Terms and Conditions
  • Archive
    • PDF Editions
  • Contacts
  • Extra Times
    • Drive In
    • Book It
    • tTunes
    • Features
    • World of Bacchus
    • Taste of Edesia
Loading Comments...

You must be logged in to post a comment.

%d